marketcaparena
Search

    XGN

    EXAGEN INC.

    Company overview

    Market capitalization
    $205.43M
    Employees
    216
    Latest publication
    2026-09-29
    About EXAGEN INC.

    Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company's lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus platform, a cornerstone of the SLE assessment that begins by quantifying the level of CB-CAPs biomarkers (EC4d and BC4d) in the patient's blood; and AVISE APS that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE Anti-Histone, a test for autoantibodies to histone proteins; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP, a biomarker-driven RA prognostic test. Further, the company offers AVISE SLE Monitor, a blood test that employs CB-CAPs technology; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop T-Cell biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20182018-12-31 · USDQ4 20132013-12-31 · USDQ3 20132013-09-30 · USDQ2 20132013-06-30 · USDQ1 20132013-03-31 · USD
    Total Revenue19,941,000USD9,641,000USD1,093,000USD935,000USD664,000USD363,000USD
    Cost Of Revenue7,724,000USD4,003,000USD881,000USD745,000USD687,000USD517,000USD
    Gross Profit12,217,000USD5,638,000USD212,000USD190,000USD-23,000USD-154,000USD
    Research Development1,426,000USD533,000USD230,000USD210,000USD226,000USD231,000USD
    Selling General Administrative12,513,000USD4,956,000USD2,053,000USD1,602,000USD1,505,000USD1,404,000USD
    Total Operating Expenses13,939,000USD5,789,000USD2,551,000USD1,958,000USD2,137,000USD2,065,000USD
    Operating Income-1,722,000USD-151,000USD-2,673,000USD-2,078,000USD-1,863,000USD-1,909,000USD
    Total Other Income Expense Net-1,474,000USD-1,108,000USD-3,773,000USD-345,000USD-447,000USD-366,000USD
    Interest Expense1,201,000USD770,000USD359,000USD376,000USD——
    Income Before Tax-3,196,000USD-1,259,000USD-6,446,000USD-2,423,000USD-2,310,000USD-2,275,000USD
    Income Tax Expense0USD751,000USD11,000USD10,000USD11,000USD10,000USD
    Net Income-3,196,000USD-1,317,000USD-6,457,000USD-2,433,000USD-2,936,000USD-2,853,000USD
    Selling And Marketing Expenses—300,000USD215,000USD92,000USD56,000USD66,000USD
    Tax Provision—58,000USD————
    Net Income From Continuing Ops—-1,536,500USD————
    Ebit—-489,000USD-2,467,000USD-2,047,000USD-1,863,000USD-1,909,000USD
    Ebitda—-334,000USD-2,347,000USD-1,931,000USD-1,748,000USD-1,805,000USD
    Depreciation And Amortization—155,000USD120,000USD116,000USD115,000USD104,000USD
    Reconciled Depreciation—155,000USD120,000USD116,000USD——
    Non Operating Income Net Other—0USD————
    Minority Interest—0USD————
    Discontinued Operations—0USD————
    Net Income Applicable To Common Shares—-4,348,500USD————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets51,935,000USD51,957,000USD58,022,000USD62,823,000USD58,760,000USD40,294,000USD44,689,000USD43,605,000USD
    Cash And Equivalents24,588,000USD———————
    Total Current Assets42,857,000USD43,583,000USD48,893,000USD52,589,000USD50,986,000USD32,505,000USD36,455,000USD35,557,000USD
    Other Current Assets5,862,000USD6,297,000USD5,818,000USD2,320,000USD5,549,000USD6,583,000USD6,584,000USD1,201,000USD
    Other Non Current Assets560,000USD———————
    Total Liabilities39,719,000USD———————
    Total Current Liabilities13,457,000USD12,564,000USD14,159,000USD12,890,000USD10,295,000USD13,995,000USD13,506,000USD8,777,000USD
    Other Current Liabilities4,939,000USD———————
    Total Stockholder Equity12,216,000USD14,432,000USD17,449,000USD18,138,000USD21,034,000USD6,403,000USD9,540,000USD12,868,000USD
    Total Equity Including Noncontrolling Interest12,216,000USD———————
    Short Long Term Debt517,000USD580,000USD643,000USD680,000USD667,000USD2,535,000USD423,000USD430,000USD
    Long Term Debt22,322,000USD22,291,000USD22,264,000USD22,261,000USD22,310,000USD18,405,000USD19,822,000USD19,823,000USD
    Deferred Revenue1,492,000USD———————
    Net Receivables12,407,000USD15,773,000USD10,855,000USD11,092,000USD15,404,000USD14,728,000USD7,835,000USD9,387,000USD
    Property Plant Equipment Net8,518,000USD7,790,000USD8,373,000USD9,179,000USD6,511,000USD7,193,000USD7,684,000USD7,485,000USD
    Accounts Payable4,439,000USD4,159,000USD4,152,999USD3,559,000USD2,510,000USD4,509,000USD4,137,000USD1,105,000USD
    Short Term Debt979,000USD2,952,000USD3,004,000USD3,006,000USD1,827,000USD3,662,000USD1,720,000USD1,778,000USD
    Common Stock24,000USD24,000USD23,000USD23,000USD22,000USD18,000USD18,000USD18,000USD
    Retained Earnings-321,445,000USD-318,249,000USD-314,282,000USD-309,609,000USD-302,522,000USD-298,083,000USD-294,331,000USD-290,570,000USD
    Total Liab—37,525,000USD40,573,000USD44,685,000USD37,726,000USD33,891,000USD35,149,000USD30,737,000USD
    Other Current Liab—4,772,000USD7,002,001USD5,684,000USD4,942,000USD4,948,000USD6,916,000USD5,894,000USD
    Capital Stock—24,000USD23,000USD23,000USD22,000USD18,000USD18,000USD18,000USD
    Cash—21,513,000USD32,220,000USD35,652,000USD30,033,000USD11,194,000USD22,036,000USD22,035,000USD
    Cash And Short Term Investments—21,513,000USD32,220,000USD35,652,000USD30,033,000USD11,194,000USD22,036,000USD22,035,000USD
    Current Deferred Revenue—681,000USD675,000USD641,000USD1,016,000USD876,000USD733,000USD-7,242,000USD
    Net Debt—3,841,000USD-4,554,000USD-7,485,000USD-4,829,000USD12,242,000USD1,170,000USD1,518,000USD
    Short Long Term Debt Total—25,354,000USD27,666,000USD28,167,000USD25,204,000USD23,436,000USD23,206,000USD23,553,000USD
    Property Plant Equipment Gross—15,524,000USD15,517,000USD15,936,000USD12,874,000USD13,292,000USD13,696,000USD13,084,000USD
    Common Stock Shares Outstanding—23,854,997shares21,558,245shares22,940,412shares21,085,749shares18,557,390shares18,203,044shares18,254,937shares
    Non Current Assets Total—8,374,000USD9,129,000USD10,234,000USD7,774,000USD7,789,000USD8,234,000USD8,048,000USD
    Non Current Liabilities Total—24,961,000USD26,414,000USD31,795,000USD27,431,000USD19,896,000USD21,643,000USD21,960,000USD
    Non Current Liabilities Other—1,792,000USD1,960,000USD2,141,000USD91,000USD122,000USD157,000USD185,000USD
    Non Currrent Assets Other—584,000USD556,000USD855,000USD1,263,000USD596,000USD550,000USD563,000USD
    Net Working Capital—31,019,000USD34,734,000USD39,699,000USD40,691,000USD18,510,000USD22,949,000USD26,780,000USD
    Unclassified Equity—332,633,000USD331,685,000USD327,701,000USD323,512,000USD304,450,000USD303,835,000USD303,402,000USD
    Unclassified Current Liabilities——-1,318,000USD——-2,535,000USD——
    Unclassified Non Current Liabilities——2,190,000USD7,393,000USD5,030,000USD1,369,000USD1,664,000USD1,952,000USD
    Inventory———3,525,000USD———2,934,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets58,022,000USD44,689,000USD56,944,000USD86,221,000USD123,445,000USD78,375,000USD88,310,000USD28,887,000USD
    Other Current Assets5,818,000USD6,584,000USD4,797,000USD4,143,000USD3,638,000USD4,159,000USD3,451,000USD2,196,000USD
    Total Liab40,573,000USD35,149,000USD34,250,000USD43,761,000USD38,509,000USD36,536,000USD32,651,000USD35,621,000USD
    Total Stockholder Equity17,449,000USD9,540,000USD22,694,000USD42,460,000USD84,936,000USD41,839,000USD55,659,000USD-6,734,000USD
    Other Current Liab6,327,000USD6,916,000USD7,531,000USD4,647,000USD6,239,000USD5,449,000USD4,181,000USD7,592,000USD
    Common Stock23,000USD18,000USD17,000USD17,000USD16,000USD13,000USD13,000USD12,000USD
    Capital Stock23,000USD18,000USD17,000USD17,000USD16,000USD13,000USD13,000USD105,232,000USD
    Retained Earnings-314,282,000USD-294,331,000USD-279,216,000USD-255,527,000USD-208,140,000USD-181,289,000USD-164,602,000USD-152,564,000USD
    Cash32,220,000USD22,036,000USD36,493,000USD62,391,000USD99,442,000USD57,448,000USD72,084,000USD13,164,000USD
    Cash And Short Term Investments32,220,000USD22,036,000USD36,493,000USD62,391,000USD99,442,000USD57,448,000USD72,084,000USD13,164,000USD
    Total Current Assets48,893,000USD36,455,000USD47,841,000USD72,611,000USD112,734,000USD70,517,000USD81,250,000USD21,312,000USD
    Total Current Liabilities14,159,000USD13,506,000USD11,902,000USD9,623,000USD9,318,000USD8,771,000USD5,895,000USD8,952,000USD
    Current Deferred Revenue675,000USD733,000USD2,001,000USD————3,842,000USD
    Net Debt-6,514,000USD1,170,000USD-13,262,000USD-27,190,000USD-71,377,000USD-30,481,000USD-46,230,000USD11,534,000USD
    Short Term Debt3,004,000USD1,720,000USD1,240,000USD1,930,000USD587,000USD308,000USD238,000USD81,000USD
    Short Long Term Debt643,000USD423,000USD264,000USD190,000USD———0USD
    Short Long Term Debt Total25,706,000USD23,206,000USD23,231,000USD35,201,000USD28,065,000USD26,967,000USD26,092,000USD24,698,000USD
    Long Term Debt22,264,000USD19,822,000USD19,231,000USD28,778,000USD27,478,000USD26,659,000USD25,854,000USD24,617,000USD
    Net Receivables10,855,000USD7,835,000USD6,551,000USD6,077,000USD9,654,000USD8,910,000USD5,715,000USD5,952,000USD
    Accounts Payable4,153,000USD4,137,000USD3,131,000USD3,046,000USD2,492,000USD3,014,000USD1,476,000USD1,279,000USD
    Property Plant Equipment Net8,373,000USD7,684,000USD8,487,000USD13,082,000USD4,772,000USD2,102,000USD1,380,000USD1,566,000USD
    Property Plant Equipment Gross15,517,000USD13,696,000USD14,256,000USD13,082,000USD4,772,000USD2,102,000USD1,380,000USD1,566,000USD
    Common Stock Shares Outstanding21,558,245shares18,203,044shares17,679,467shares17,082,348shares15,972,256shares12,652,308shares12,560,990shares63,005shares
    Non Current Assets Total9,129,000USD8,234,000USD9,103,000USD13,610,000USD10,711,000USD7,858,000USD7,060,000USD7,575,000USD
    Non Current Liabilities Total26,414,000USD21,643,000USD22,348,000USD34,138,000USD29,191,000USD27,765,000USD26,756,000USD26,669,000USD
    Non Current Liabilities Other1,960,000USD157,000USD357,000USD867,000USD1,407,000USD948,000USD638,000USD304,000USD
    Non Currrent Assets Other556,000USD550,000USD616,000USD528,000USD433,000USD250,000USD174,000USD-24,000USD
    Net Working Capital34,734,000USD22,949,000USD35,939,000USD62,988,000USD103,416,000USD61,746,000USD75,355,000USD12,360,000USD
    Unclassified Non Current Liabilities2,190,000USD1,664,000USD2,760,000USD4,474,000USD-1,407,000USD——1,078,000USD
    Unclassified Equity331,685,000USD303,835,000USD301,876,000USD297,953,000USD293,044,000USD223,102,000USD308,545,000USD42,405,000USD
    Inventory——2,871,000USD1,795,000USD1,091,000USD1,203,000USD1,427,000USD1,022,000USD
    Accumulated Other Comprehensive Income——0USD0USD—0USD-88,310,000USD-1,819,000USD
    Unclassified Current Assets——-2,871,000USD-1,795,000USD—-1,203,000USD-1,427,000USD-1,022,000USD
    Unclassified Current Liabilities——-2,265,000USD————-3,842,000USD
    Other Liab———19,000USD1,713,000USD530,000USD266,000USD270,000USD
    Good Will———0USD5,506,000USD5,506,000USD5,506,000USD5,506,000USD
    Other Assets———528,000USD433,000USD250,000USD174,000USD503,000USD
    Net Tangible Assets———42,460,000USD79,430,000USD36,333,000USD50,153,000USD-117,472,000USD
    Intangible Assets————5,506,000USD5,506,000USD5,506,000USD0USD
    Unclassified Non Current Assets————-5,939,000USD-5,756,000USD-5,680,000USD—
    Deferred Long Term Liab———————400,000USD
    Long Term Investments———————0USD
    Short Term Investments———————0USD
    Accumulated Depreciation———————0USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-3,967,000USD-4,673,000USD-7,087,000USD-4,439,000USD-3,752,000USD-3,761,000USD-5,028,000USD-2,966,000USD
    Depreciation599,000USD600,000USD612,000USD466,000USD440,000USD415,000USD422,000USD429,000USD
    Stock Based Compensation655,000USD705,000USD593,000USD443,000USD417,000USD433,000USD217,000USD560,000USD
    Other Non Cash Items69,000USD-944,000USD2,863,000USD1,762,000USD349,999USD340,000USD326,000USD404,000USD
    Change To Account Receivables-4,918,000USD237,000USD3,635,000USD1,000USD-6,893,000USD1,552,000USD2,316,000USD-802,000USD
    Change In Working Capital-7,773,000USD1,299,000USD5,963,000USD-1,117,000USD-8,125,999USD2,936,000USD1,887,000USD-853,000USD
    Total Cash From Operating Activities-10,417,000USD-3,013,000USD2,944,000USD-2,885,000USD-10,671,000USD363,000USD-2,176,000USD-2,426,000USD
    Capital Expenditures-228,000USD-44,000USD-275,000USD-209,000USD-113,000USD-146,000USD-147,000USD-136,000USD
    Free Cash Flow-10,645,000USD-3,057,000USD2,669,000USD-3,094,000USD-10,784,000USD217,000USD-2,323,000USD-2,562,000USD
    Total Cashflows From Investing Activities-228,000USD-35,000USD-275,000USD-209,000USD-107,000USD-146,000USD-147,000USD-136,000USD
    Net Borrowings-357,000USD-346,000USD-336,000USD3,760,000USD-197,000USD-216,000USD-215,000USD—
    Total Cash From Financing Activities-62,000USD-384,000USD2,950,000USD21,933,000USD-64,000USD-216,000USD-121,000USD-226,000USD
    Sale Purchase Of Stock295,000USD—199,000USD1,000USD198,000USD—72,000USD—
    Change In Cash-10,707,000USD-3,432,000USD5,619,000USD18,839,000USD-10,842,000USD1,000USD-2,444,000USD-2,788,000USD
    Begin Period Cash Flow32,420,000USD35,652,000USD30,033,000USD11,394,000USD22,236,000USD22,235,000USD24,679,000USD27,267,000USD
    End Period Cash Flow21,713,000USD32,220,000USD35,652,000USD30,233,000USD11,394,000USD22,236,000USD22,235,000USD24,479,000USD
    Other Cashflows From Financing Activities-62,000USD—2,950,000USD21,933,000USD-64,000USD104,000USD94,000USD-136,000USD
    Issuance Of Capital Stock—-38,000USD3,286,000USD—————
    Investments——-275,000USD-209,000USD-107,000USD-146,000USD-147,000USD-136,000USD
    Unclassified Financing Cash Flow———-3,761,000USD————
    Other Cashflows From Investing Activities————6,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-19,951,000USD-15,115,000USD-23,689,000USD-47,387,000USD-26,851,000USD-16,687,000USD-12,038,000USD-8,012,000USD
    Depreciation2,118,000USD1,724,000USD2,168,000USD1,557,000USD948,000USD546,000USD591,000USD731,000USD
    Stock Based Compensation2,158,000USD1,763,000USD3,617,000USD4,704,000USD4,728,000USD2,694,000USD572,000USD114,000USD
    Other Non Cash Items4,031,000USD1,425,000USD3,117,000USD7,618,000USD819,000USD805,000USD1,237,000USD1,426,000USD
    Change To Account Receivables-3,020,000USD-1,284,000USD-474,000USD3,577,000USD-744,000USD-3,195,000USD237,000USD-2,262,000USD
    Change In Working Capital-1,981,000USD-3,076,000USD325,000USD1,670,000USD-61,000USD-1,336,000USD174,000USD-3,591,000USD
    Total Cash From Operating Activities-13,625,000USD-13,279,000USD-14,462,000USD-32,144,000USD-20,269,000USD-14,084,000USD-9,711,000USD-9,301,000USD
    Capital Expenditures-641,000USD-515,000USD-828,000USD-4,318,000USD-2,370,000USD-455,000USD-403,000USD-199,000USD
    Free Cash Flow-14,266,000USD-13,794,000USD-15,290,000USD-36,462,000USD-22,639,000USD-14,539,000USD-10,114,000USD-9,500,000USD
    Total Cashflows From Investing Activities-626,000USD-515,000USD-804,000USD-4,318,000USD-2,420,000USD-455,000USD-103,000USD-199,000USD
    Net Borrowings2,881,000USD-861,000USD-10,938,000USD-696,000USD-525,000USD-249,000USD-138,000USD4,962,000USD
    Total Cash From Financing Activities24,435,000USD-663,000USD-10,632,000USD-489,000USD64,683,000USD-97,000USD68,734,000USD11,423,000USD
    Issuance Of Capital Stock22,025,000USD0USD—0USD69,144,000USD13,000USD68,872,000USD6,466,000USD
    Change In Cash10,184,000USD-14,457,000USD-25,898,000USD-36,951,000USD41,994,000USD-14,636,000USD58,920,000USD1,923,000USD
    Begin Period Cash Flow22,236,000USD36,693,000USD62,591,000USD99,542,000USD57,548,000USD72,184,000USD13,264,000USD11,341,000USD
    End Period Cash Flow32,420,000USD22,236,000USD36,693,000USD62,591,000USD99,542,000USD57,548,000USD72,184,000USD13,264,000USD
    Investments—-515,000USD-1,126,000USD-4,318,000USD-2,420,000USD-455,000USD-103,000USD-199,000USD
    Sale Purchase Of Stock—176,000USD279,000USD-239,000USD390,000USD142,000USD6,741,000USD6,466,000USD
    Other Cashflows From Financing Activities—198,000USD306,000USD-239,000USD-3,936,000USD3,004,000USD18,424,000USD12,932,000USD
    Dividends Paid——-9,935,000USD—-390,000USD-142,000USD-6,741,000USD0USD
    Other Cashflows From Investing Activities——24,000USD—-50,000USD-50,000USD300,000USD-50,000USD
    Unclassified Investing Cash Flow——1,126,000USD4,318,000USD2,420,000USD———
    Unclassified Financing Cash Flow——9,656,000USD—69,144,000USD-2,852,000USD50,448,000USD-12,937,000USD
    Change To Liabilities———901,000USD329,000USD986,000USD528,000USD-824,000USD
    Cash And Cash Equivalents Changes————41,994,000USD——0USD
    Change To Inventory——————-567,000USD-497,000USD
    Exchange Rate Changes———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2020Quarterly · 2020-03-31SegmentAll Other Segments195,000USD0001274737-20-000037
    Q1 2020Quarterly · 2020-03-31SegmentClient1,082,000USD0001274737-20-000037
    Q1 2020Quarterly · 2020-03-31SegmentGovernment2,245,000USD0001274737-20-000037
    Q1 2020Quarterly · 2020-03-31SegmentHealthcare Insurers6,062,000USD0001274737-20-000037
    Q1 2020Quarterly · 2020-03-31SegmentJanssen SIMPONI0USD0001274737-20-000037
    FY 2019Yearly · 2019-12-31SegmentAll Other Segments639,000USD0001274737-20-000026
    FY 2019Yearly · 2019-12-31SegmentClient4,392,000USD0001274737-20-000026
    FY 2019Yearly · 2019-12-31SegmentGovernment9,896,000USD0001274737-20-000026
    FY 2019Yearly · 2019-12-31SegmentHealthcare Insurers23,984,000USD0001274737-20-000026
    FY 2019Yearly · 2019-12-31SegmentJanssen SIMPONI1,476,000USD0001274737-20-000026
    Q3 2019Quarterly · 2019-09-30SegmentAll Other Segments179,000USD0001628280-19-014001
    Q3 2019Quarterly · 2019-09-30SegmentClient1,007,000USD0001628280-19-014001
    Q3 2019Quarterly · 2019-09-30SegmentGovernment2,665,000USD0001628280-19-014001
    Q3 2019Quarterly · 2019-09-30SegmentHealthcare Insurers6,188,000USD0001628280-19-014001
    Q3 2019Quarterly · 2019-09-30SegmentJanssen SIMPONI400,000USD0001628280-19-014001
    Q1 2019Quarterly · 2019-03-31SegmentAll Other Segments162,000USD0001274737-20-000037
    Q1 2019Quarterly · 2019-03-31SegmentClient1,105,000USD0001274737-20-000037
    Q1 2019Quarterly · 2019-03-31SegmentGovernment2,432,000USD0001274737-20-000037
    Q1 2019Quarterly · 2019-03-31SegmentHealthcare Insurers5,461,000USD0001274737-20-000037
    Q1 2019Quarterly · 2019-03-31SegmentJanssen SIMPONI100,000USD0001274737-20-000037
    FY 2018Yearly · 2018-12-31SegmentAll Other Segments738,000USD0001274737-20-000026
    FY 2018Yearly · 2018-12-31SegmentClient608,000USD0001274737-20-000026
    FY 2018Yearly · 2018-12-31SegmentGovernment10,024,000USD0001274737-20-000026
    FY 2018Yearly · 2018-12-31SegmentHealthcare Insurers21,070,000USD0001274737-20-000026
    FY 2018Yearly · 2018-12-31SegmentJanssen SIMPONI0USD0001274737-20-000026
    Q3 2018Quarterly · 2018-09-30SegmentAll Other Segments120,000USD0001628280-19-014001
    Q3 2018Quarterly · 2018-09-30SegmentClient171,000USD0001628280-19-014001
    Q3 2018Quarterly · 2018-09-30SegmentGovernment2,524,000USD0001628280-19-014001
    Q3 2018Quarterly · 2018-09-30SegmentHealthcare Insurers5,408,000USD0001628280-19-014001
    Q3 2018Quarterly · 2018-09-30SegmentJanssen SIMPONI0USD0001628280-19-014001

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.